Paper2840367
Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.
Lauritsen K and 3 others. Gut, 1988. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis. Papers, record 2840367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2840367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Longterm olsalazine treatment: pharmacokinetics, tolerance and effects on local eicosanoid formation in ulcerative colitis and Crohn's colitis.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminosalicylic Acids | Major topic |
| Colitis, Ulcerative | Major topic |
| Crohn Disease | Major topic |
| Leukotriene B4 | Major topic |
| Prostaglandins E | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Dinoprostone | |
| Feces | |
| Female | |
| Humans | |
| Male | |
| Mesalamine | |
| Middle Aged | |
| Rectum |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5474435 | A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. | Scand J Gastroenterol | 1970 | https://conductscience.org/library/papers/5474435 | PubMed |
| 2 | 13994348 | Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. | Br Med J | 1962 | https://conductscience.org/library/papers/13994348 | PubMed |
| 3 | 4146729 | Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4146729 | PubMed |
| 4 | 4150435 | A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). | Gut | 1973 | https://conductscience.org/library/papers/4150435 | PubMed |
| 5 | 72239 | An experiment to determine the active therapeutic moiety of sulphasalazine. | Lancet | 1977 | https://conductscience.org/library/papers/72239 | PubMed |
| 6 | 36332 | Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin). | Gut | 1979 | https://conductscience.org/library/papers/36332 | PubMed |
| 7 | 38175 | National Cooperative Crohn's Disease Study: study design and conduct of the study. | Gastroenterology | 1979 | https://conductscience.org/library/papers/38175 | PubMed |
| 8 | 467941 | Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). | Gastroenterology | 1979 | https://conductscience.org/library/papers/467941 | PubMed |
| 9 | 38176 | National Cooperative Crohn's Disease Study: results of drug treatment. | Gastroenterology | 1979 | https://conductscience.org/library/papers/38176 | PubMed |
| 10 | 6104551 | A critical survey of controlled studies in the treatment of ulcerative colitis and Crohn's disease. | Clin Gastroenterol | 1980 | https://conductscience.org/library/papers/6104551 | PubMed |
| 11 | 6105118 | Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. | Gut | 1980 | https://conductscience.org/library/papers/6105118 | PubMed |
| 12 | 6107263 | Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. | Gut | 1980 | https://conductscience.org/library/papers/6107263 | PubMed |
| 13 | 6107853 | Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. | N Engl J Med | 1980 | https://conductscience.org/library/papers/6107853 | PubMed |
| 14 | 7010522 | The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis. | Scand J Gastroenterol | 1980 | https://conductscience.org/library/papers/7010522 | PubMed |
| 15 | 6114321 | Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. | Lancet | 1981 | https://conductscience.org/library/papers/6114321 | PubMed |
| 16 | 6791938 | Prostaglandin E2 in jejunal fluids and its potential diagnostic value for selecting patients with indomethacin-sensitive diarrhoea. | Eur J Clin Invest | 1981 | https://conductscience.org/library/papers/6791938 | PubMed |
| 17 | 6980161 | Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. | Gastroenterology | 1982 | https://conductscience.org/library/papers/6980161 | PubMed |
| 18 | 6126420 | Will there be a next generation of sulfasalazine? | Gastroenterology | 1982 | https://conductscience.org/library/papers/6126420 | PubMed |
| 19 | 7173720 | Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. | Gut | 1982 | https://conductscience.org/library/papers/7173720 | PubMed |
| 20 | 6573927 | Comparison of radioimmunological determinations with gas chromatography mass spectrometry dosage. A study of PGE2 and PGF2alpha in gastrointestinal fluids. | Biomed Mass Spectrom | 1983 | https://conductscience.org/library/papers/6573927 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37056732 | Crosstalk between omega-6 oxylipins and the enteric nervous system: Implications for gut disorders? | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37056732 | PubMed |
| 18475455 | Mechanism of action of 5-arninosalicylic acid. | Mediators Inflamm | 1992 | https://conductscience.org/library/papers/18475455 | PubMed |
| 7729283 | Effect of olsalazine on sodium-dependent bile acid transport in rat ileum. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7729283 | PubMed |
| 2664059 | Inflammatory intermediaries in inflammatory bowel disease. | Int J Colorectal Dis | 1989 | https://conductscience.org/library/papers/2664059 | PubMed |
| 2651087 | Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease. | Drugs | 1989 | https://conductscience.org/library/papers/2651087 | PubMed |
| 2253912 | Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. | Gut | 1990 | https://conductscience.org/library/papers/2253912 | PubMed |
| 2199130 | Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II). | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2199130 | PubMed |
| 1711964 | Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease. | Drugs | 1991 | https://conductscience.org/library/papers/1711964 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2840367
GET https://conductscience.org/api/papers/v1/2840367/references?page=2